Why is Beryl Drugs falling/rising?

As of 19-Nov, Beryl Drugs Ltd is experiencing a decline in its stock price, currently at Rs 22.25, which represents a decrease of Rs 1.12 or 4.79%. The stock has been underperforming, having lost 7.64% over the last four days, and it is trading below all key moving averages, indicating a bearish trend. Additionally, the stock's delivery volume has significantly decreased by 94.66% compared to the 5-day average, suggesting a lack of investor interest. The stock has also shown poor performance over various time frames, with a year-to-date decline of 38.45%, further contributing to the negative sentiment surrounding it.
In the broader market context, Beryl Drugs' recent performance contrasts sharply with the Sensex, which has gained 0.85% over the past week and 9.02% year-to-date. This underperformance highlights the stock's struggles relative to the overall market, as it has consistently lagged behind the benchmark in both short-term and long-term returns. The lack of positive factors available for analysis further emphasizes the challenges faced by Beryl Drugs, reinforcing the downward pressure on its stock price amidst a generally more favorable market environment.